Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Olink Proteomics AB
AB
Active
Org 5590468632
Salagatan 16 A, 753 30
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 10 years old
394 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Olink Proteomics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
EM
Eva Maria Liminga Björk
Chief Executive Officer
Chief Executive Officer
2026
LM
Lina Maria Josefine Jernebring
Chief Auditor
Chief Auditor
2025
Former (6)
AM
Anna Maria Marsell
Chief Executive Officer
Chief Executive Officer
2024 – 2026
FO
Fredrik Oskar Norrman
Chief Auditor
Chief Auditor
2022 – 2024
EE
Elias Ego
Authorized Recipient of Service
Authorized Recipient of Service
2026 – 2026
JM
Jakob Marek Wojcik
Chief Auditor
Chief Auditor
2024 – 2025
PJ
Per Johan Engstam
Chief Auditor
Chief Auditor
2021 – 2022
KL
Karl Leonard Daun
Chief Auditor
Chief Auditor
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
BM
Bram Monster
Board of Directors
Board of Directors
2024
PT
Petrus Thomas Adrianus van der Zande
Chairman
Chairman
2025
MV
Michel Verhoosel
Board of Directors
Board of Directors
2024
Former (8)
RE
Rickard El Tarzi
Chairman
Chairman
2020 – 2020
JM
Johan Magnus Lyth
Board of Directors
Board of Directors
2024 – 2024
TM
Tommy Mattias Jansson
Board of Directors
Board of Directors
2022 – 2024
JA
Jon Aron Olof Heimer
Chairman
Chairman
2022 – 2024
AH
Anthony Hugh Smith
Chairman
Chairman
2024 – 2025
GO
Gustaf Oskar Hjelm
Chairman
Chairman
2024 – 2024
PM
Per Magnus Eriksson
Deputy Board Member
Deputy Board Member
2020 – 2022
TM
Tommi Markus Unkuri
Chairman
Chairman
2020 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Olink Holding Ab (Publ)
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Olink Proteomics AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network